Annual Cash & Cash Equivalents
$135.70 M
+$54.36 M+66.82%
December 31, 2023
Summary
- As of February 8, 2025, ALGS annual cash & cash equivalents is $135.70 million, with the most recent change of +$54.36 million (+66.82%) on December 31, 2023.
- During the last 3 years, ALGS annual cash & cash equivalents has fallen by -$84.68 million (-38.42%).
- ALGS annual cash & cash equivalents is now -38.42% below its all-time high of $220.38 million, reached on December 31, 2020.
Performance
ALGS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$35.33 M
-$9.75 M-21.62%
September 30, 2024
Summary
- As of February 8, 2025, ALGS quarterly cash and cash equivalents is $35.33 million, with the most recent change of -$9.75 million (-21.62%) on September 30, 2024.
- Over the past year, ALGS quarterly cash and cash equivalents has dropped by -$100.37 million (-73.96%).
- ALGS quarterly cash and cash equivalents is now -85.26% below its all-time high of $239.73 million, reached on September 30, 2021.
Performance
ALGS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ALGS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +66.8% | -74.0% |
| 3 y3 years | -38.4% | -55.1% |
| 5 y5 years | +464.6% | -55.1% |
ALGS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.4% | +66.8% | -81.1% | +46.3% |
| 5 y | 5-year | -38.4% | +95.1% | -85.3% | +46.3% |
| alltime | all time | -38.4% | +464.6% | -85.3% | +46.3% |
Aligos Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $35.33 M(-21.6%) |
| Jun 2024 | - | $45.08 M(+86.7%) |
| Mar 2024 | - | $24.15 M(-82.2%) |
| Dec 2023 | $135.70 M(+66.8%) | $135.70 M(+92.7%) |
| Sep 2023 | - | $70.43 M(-22.5%) |
| Jun 2023 | - | $90.83 M(+15.5%) |
| Mar 2023 | - | $78.67 M(-3.3%) |
| Dec 2022 | $81.35 M | $81.35 M(-5.9%) |
| Sep 2022 | - | $86.44 M(+21.5%) |
| Jun 2022 | - | $71.17 M(-31.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $104.56 M(-44.0%) |
| Dec 2021 | $186.82 M(-15.2%) | $186.82 M(-22.1%) |
| Sep 2021 | - | $239.73 M(+27.8%) |
| Jun 2021 | - | $187.65 M(-6.3%) |
| Mar 2021 | - | $200.36 M(-9.1%) |
| Dec 2020 | $220.38 M(+216.8%) | $220.38 M(+592.7%) |
| Sep 2020 | - | $31.82 M(-49.9%) |
| Jun 2020 | - | $63.45 M(-8.8%) |
| Dec 2019 | $69.56 M(+189.4%) | $69.56 M |
| Dec 2018 | $24.04 M | - |
FAQ
- What is Aligos Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aligos Therapeutics?
- What is Aligos Therapeutics annual cash & cash equivalents year-on-year change?
- What is Aligos Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Aligos Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ALGS is $135.70 M
What is the all time high annual cash & cash equivalents for Aligos Therapeutics?
Aligos Therapeutics all-time high annual cash & cash equivalents is $220.38 M
What is Aligos Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ALGS annual cash & cash equivalents has changed by +$54.36 M (+66.82%)
What is Aligos Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ALGS is $35.33 M
What is the all time high quarterly cash and cash equivalents for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly cash and cash equivalents is $239.73 M
What is Aligos Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ALGS quarterly cash and cash equivalents has changed by -$100.37 M (-73.96%)